Send us Fan Mail Leslie Norwalk, former Acting Administrator of the Centers for Medicare and Medicaid Services under President George W. Bush, joins Adam Goodman on 13th and Park for a candid inside look at how American healthcare is actually governed, regulated, and paid for. Drawing on her legal background, six years at CMS, and four years in the White House, Norwalk explains why the interplay between government regulators and private industry is not a conflict of interest but a necessity, and why refusing to listen to industry often produces bad law with unintended consequences for the very patients those laws are meant to protect. Norwalk takes the conversation back to one of the most consequential policy achievements of the Bush era: the creation of Medicare Part D, the prescription drug benefit that now covers 57 million beneficiaries. She recalls the skepticism inside and outside government about whether insurers and pharmacy benefit managers would even participate, the frantic phone calls she made to convince them to join, and how the program ultimately came in at roughly half its projected cost, partly because of a structural decision to let PBMs negotiate freely without Medicare interference. She also breaks down the infamous donut hole, the coverage gap that was hated by beneficiaries but was the price of keeping the program's price tag under the $400 billion ceiling Congress had set. The conversation moves to bigger questions about the future of the system: why Medicare was built to pay for sick care rather than prevention, why administration after administration fails to bend the cost curve, and where artificial intelligence could make a genuine difference, specifically in pattern recognition in radiology and pathology, AI-guided robotic surgery, and digesting the overwhelming volume of clinical trial data that no physician or coverage writer can realistically track on their own. Norwalk draws a parallel between the federal response to Hurricane Katrina and the COVID-19 pandemic, explaining how the creative workarounds CMS improvised during the flooding in New Orleans became a direct template for how the agency responded when hospitals went dark during the pandemic. Norwalk closes with a clear-eyed take on the profit question in healthcare: margin is not the enemy, because without margin there is no access and no services. The real challenge is finding the sweet spot where reimbursement is high enough to sustain innovation and access but calibrated against the full value a treatment delivers, not just its sticker price. It is a conversation about power, perspective, and the enormous distance between how American healthcare is designed and how it is actually experienced by the people it is meant to serve. Chapters 0:00 Intro 1:37 Leslie's Background and CMS Role 3:20 Government vs. Private Sector 8:30 Building Medicare Part D 11:43 Can Healthcare Actually Be Fixed? 13:36 Prevention vs. Treatment 15:47 AI in Healthcare and CMS 18:03 Hurricane Katrina and COVID Lessons 21:03 One Reform After the Midterms 23:45 Profit, Margin, and the Sweet Spot 26:14 The Human Cost of Public Service 27:00 Closing Thoughts 40:34 The Donut Hole Explained Follow Us! X: https://x.com/13thandPark IG: https://www.instagram.com/13th_and_park/ LinkedIn: https://www.linkedin.com/company/13thandpark TikTok: https://www.tiktok.com/@13th_and_park #healthcare #medicare #medicaid #healthpolicy #cms #aihealthcare #prescriptiondrugs #medicarepartd #healthcarereform #washingtondc #13thandpark #ballardpartners #publichealth #healthcarecosts #governmentpolicy
Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.
Transcript
From the show. Tap a time to play from there.
SPEAKER_01The other component where I could imagine AI being super important is digesting of all the randomized clinical trials. You know, if you're a practicing physician or surgeon, how do you keep on top of all that? Well, exactly. And even if you're an insurance company and you're writing coverage policies, or you're the Medicare program and you're writing coverage policies, what is it that you can do to keep on top of it all?
SPEAKER_03Most of us see health care from the waiting room. But Leslie Norwalk has seen it from the rooms where major health decisions are made for all of us. The former acting CMS administrator under President George W. Bush, who oversaw two of America's most consequential health care programs, Norwalk now advises companies on the role they can play in advancing the nation's health agenda. Today's conversation is about power, perspective, and the distance between how healthcare is designed and experienced.
SPEAKER_03Because in a system with so many seats at the table, the patient seat shouldn't be the one that's hardest to find.
SPEAKER_03Leslie, you've had a seat at many different tables. You've had a seat at the table of government, you've had a seat in the private sector. So you've seen it from the inside and the outside. What perspective did you get from each one of those seats that molded your kind of viewpoint of where you are today on healthcare policy in the country?
SPEAKER_01The legal underpinning of my background is super important because the regulatory impact on the healthcare sector cannot be understated. It's so important. And not just the state laws where I had done those 50 state surveys on utilization review and prior authorization or how you have to pay a claim or whether corporations can practice medicine, all of that. Tax work, antitrust work, everything I did when I started at Epstein Becker. And I was there for six years before I went into the government.
SPEAKER_01And then working for what is now known as the Centers for Medicare and Medicaid Services, or CMS, working for CMS that oversees the Medicare and Medicaid populations and all of those rules and regulations, appreciating how all of them impact how each type of healthcare service and treatment is provided and paid for in this country, whether it's covered, how it's covered, how much uh you're going to reimburse a hospital or a physician, all of that is based often in the regulatory underpinnings of Medicare, Medicaid, as well as the state laws.
SPEAKER_01So for me, that's been the most important component of my upbringing. That and I'm a research junkie. So I love doing the research and figuring out how it all might impact the individual components of the healthcare sector.
SPEAKER_03Okay, so take it from both perspectives. What is it that maybe government needs to understand more from how they see the world? And what does government conversely, what do they need to understand more deeply about the private sector is so there's a partnership of sorts that that works for the betterment of all.
SPEAKER_01Right. What's so funny if you think about conventional wisdom that lobbyists are bad or evil and we shouldn't have lobbyists, or the revolving door of people working in industry and then going to government and coming back and so forth, and how that's somehow bad. I look at it totally differently. And I can remember when I was at CMS and we were implementing the prescription drug benefit and when I needed to better understand how would a pharmacy benefit manager work?
SPEAKER_01And I needed to learn from industry. And to your point about partnership, the importance of partnership. If you think about many of the people who work for the federal government and the people who staff senators and people in Congress generally, how do they learn about what they're regulating? And quite often they've never spent any time in a hospital on the administrative side. Maybe they've been a patient, but that's not to say that they've actually worked in a hospital or a physician's office or a long-term care facility or a whole myriad of healthcare facilities.
SPEAKER_01How do you learn about that? From my perspective, you need to learn from people in the industry. So I think that in this instance, I always used to take what a lobbyist told me or uh a member of management from a particular healthcare facility, for example. Yeah, you can take that with a grain of salt. But you can't learn about what they do unless you listen. And often by not listening, you make bad law. You have a regulatory impact that's negative. It might be negative to beneficiaries.
SPEAKER_01Yes, it could be negative to a bottom line, but that could have follow-on effects that you haven't anticipated as a regulator.
SPEAKER_00Right.
SPEAKER_01So I would say the interplay is super, super important. And the other component of that is I think the number of people who are really good staff, particularly at the agency at CMS, who work super hard and are very knowledgeable about what they've done and the impacts things have had and the importance to learn from them as a political appointee. I mean, quite often that's another trope that you would see, which is, you know, the career staff are bad.
SPEAKER_01That wasn't at all my experience.
SPEAKER_03It's interesting you say that because when Dr. Oz was on the show, one of your successors, uh, fascinating guy, right? I love being sitting down with an Emmy Award-winning personal media who knows.
SPEAKER_02In fact, what I tell my team, and I firmly believe this, is my number one job, number one job, is to hire the smartest people in America and then make sure they don't kill each other.
SPEAKER_01The challenge of running an agency like CMS, and has many, is the sheer volume of what you do. The Medicare program, the original Medicare program or Medicare fee for service as it's known, has a physician payment stream, outpatient hospital, inpatient hospital, home health, hospice, long-term care facilities, inpatient rehab facilities, so on and so forth. And all of these different payment streams grew up over time by Congress.
SPEAKER_01So that statute is something then that CMS drafts regulations about, typically on an annual basis. And they don't always speak to each other because it's been added on over time, sure, which makes it more complicated. And often there's an interplay between the Medicare program, and I like to remind people you care for the elderly and you aid the poor. So it's Medicare, typically 65 and over, and for those who qualify because of a disability. And then the Medicaid program, which is for those who are less fortunate.
SPEAKER_01And not only do you have all those different payment streams running in the Medicare program, you also have Medicaid, and sometimes individuals are eligible for both. And those two programs don't naturally speak to each other. And similarly, at least was my experience, that quite often within the agency, individuals who worked on the Medicare program were less knowledgeable about Medicaid. And of course, Medicaid is a state-based program where the federal government matches. So we like to say, you've seen one Medicaid program, you've seen one Medicaid program, and there are at least 50.
SPEAKER_01So the importance of relying on the staff is as important as it is as understanding the industry that you're regulating. And by industry, I actually mean more specific, not just healthcare, but each of the individual components that have those different payment streams, they are typically a different industry. And for me, at least, when I was at CMS, the most important thing was to figure out using what I could learn from the staff, and then augment that from what I was hearing from industry and figuring out, based on my own knowledge, what made the most sense given a particular policy goal.
SPEAKER_03When you were at CMS, people would say in hindsight, the most significant thing that happened was the course plan D. Now I think it serves 57 million beneficiaries who just had its, I think, 20th 20th anniversary. But there's an irony built into all this. The irony is that when you look for a delivery system, how do you deliver something like that? You found there was only one uh option, and that was PBMs. And now PBMs are, of course, subject to great debate here in healthcare circles in and beyond Washington.
SPEAKER_03Take us back to how that came together and the challenges you had, because I think I remember reading, Leslie, even people who were trying to build this had doubts about whether or not when it was all said and done, this would work.
SPEAKER_01It didn't exist. And there were many people who were skeptical that we could pull it off. No one's gonna come in, no one's going to insure that, that's not gonna happen. You need to have a fallback plan. In fact, Congress put in a fallback plan in case we didn't have enough people or enough insurers to provide coverage to beneficiaries around the country. And I spent many a day calling insurance companies and pharmacy benefit managers or PVMs trying to convince them to get in to the program so that we wouldn't have to have a fallback plan.
SPEAKER_01It's a very interesting thing, drug delivery in this country, because you don't just walk up to Pfizer and say, I, you know, I'd like that red pill today, please. That's not how drugs are distributed. It's incredibly complicated in terms of how a drug actually gets to a pharmacy and who pays for what, when, where, why, and how. So trying to understand that and develop a coherent policy around that within the framework that Congress gave CMS to do it is no easy thing.
SPEAKER_01But to your point about PBMs, yes, they've become controversial. But if you think about what CMS was doing in 2004, five, and six as we implemented the program before it started, PBMs were performing this service for employers all across the country. So they did prescription drug coverage typically for a health insurance company, and they were the experts in it. And so one of the other very controversial things that recently changed was that the Medicare program was not allowed to interfere with the negotiations between, say, a PBM and a pharmacy or a PBM and a drug company.
SPEAKER_01The program, as it turns out, came in the first 10 years at about half the price of what they what they originally scored. Well, and the actuary scored it even more expensive at$535 billion. So it's crazy uh how well it's it's done. And I'm of course delighted and happy anniversary.
SPEAKER_03To all of us. So change is a difficult thing for a lot of people, right? And when you're talking about change in healthcare, even more so, when you look at it now from the outside, having been in the inside, how optimistic should we be that at some point, at some point, we're gonna kind of get our act together and get control of a behemoth that is, you know, whose cost is rising astronomically every year and where the consequences of our health care are not measuring up to the investment.
SPEAKER_01I'd like to tell you I'm optimistic, but the road to innovation and I'm going to change healthcare is littered with failure. And I've had many people tell me that they're going to change the healthcare system. Companies as powerful as Amazon, Berkshire Hathaway, JP Morgan Chase hiring a tool Gawandi, terrific healthcare author, to figure out how we could drive change. Congress, over the last 60 years, have been adding to the Medicare program in a way to pay for sick care.
SPEAKER_01And so much of what we think about now and where we want to drive innovation is to keep people healthy. And the Medicare program really isn't set up for that. So figuring out how to incorporate new ideas in the Medicare program is something that administration after administration grapples with. What most of them find is that they don't save money. And it frankly could be in large part because of the population that the Medicare program serves. We tend to spend more at the end of life and a lot more the later in life you go.
SPEAKER_01And this is a country that is uncomfortable talking about death and dying often. And so we're throwing extraordinary measures at individuals who are not going to have much benefit from those measures. And, you know, it's just a part of our ethos, really.
SPEAKER_03You mentioned a couple minutes ago, prevention versus treatment. So and that's a whole RFK junior mantra. That's kind of what they're driving for. But it's new. Intuitively, it makes sense. But then you have to adjust a system that is built on the latter part of that, the treatment part, to recognize that prevention is a powerful tool that we've yet to fully utilize in healthcare.
SPEAKER_01Yeah, there's no question that it's true. I would quibble with whether or not it's new. I think even when I was at CMS, and before me, they were trying to figure out how do we incorporate prevention. The 2003 law that added the Medicare Part D drug benefit also added the welcome to Medicare physical, which was intended to be more let's do a holistic overview of individuals when they join the Medicare program. Let's be more preventative. A lot of the demonstrations and pilot projects focus on prevention as well.
SPEAKER_01But I think we can be more efficient with what we do provide when it comes to treatment. Are we providing the best treatment options that make the most sense for the patient that sits in front of us? And can we do it in a way that's providing better quality outcomes? And the triple aim of healthcare, and I'm sure Dr. Ross probably mentioned this and it's been around a long time, which is cost, quality, and access. So, how do you reduce the cost of care, still have access to anyone who needs it, and prov provide in a way that's high quality?
SPEAKER_01We've talked about how do you reduce readmissions to hospitals. One of the things that's often talked about now is how do you, once you've been discharged from a hospital, how can you make sure that the treatment after that is the most appropriate for you? So there's so many things that are important to tackle. And quite often the Medicare program isn't because it's so siloed, because of how it was grown up over time, it doesn't always make sense and doesn't necessarily have the best payment incentives to ensure that individuals are treated in the right location for the best outcome for the lowest cost.
SPEAKER_03Let's talk about AI for a second. So CMS is doing AI assisted reviews of traditional Medicare delivery. The question that kind of naturally begs itself to be asked is where's the line between allowing an algorithm to drive decision making and perhaps the best interest of the patient?
SPEAKER_01I think the answer is going to change quickly. Today there are lots of things that give me pause about AI, just from playing around on it on a day-to-day basis. I'm like, well, that's a hallucination, or even when I've used it from a work perspective or seen work product that I'm fairly certain was AI drafted. I'm like, yeah, no, that is not that term, that term does not exist. Like I don't, I don't know what that is. But I think if AI were all good, and get to that in a second, these algorithms would continue to improve. And there are a lot of reasons or places where I could see AI being immediately beneficial.
SPEAKER_01If you look, for example, at where the FDA has approved AI in the treatment paradigm, three most common areas are things where you can see pattern recognition, where algorithms make a lot of sense, dermatology, pathology, and radiology. But you could imagine basic surgery where we have a lot of robots out there now. So maybe AI-guided robotic surgery. And maybe AI-guided robotic surgery is in fact steadier than the human hand, which might shake.
SPEAKER_01The other component where I could imagine AI being super important is digesting of all the randomized clinical trials. You know, if you're a practicing physician or surgeon, how do you keep on top of all that? Well, exactly. And even if you're an insurance company and you're writing coverage policies, or you're the Medicare program and you're writing coverage policies, what is it that you can do to keep on top of it all? So I can imagine AI and those algorithms coming into the forefront in fairly short order.
SPEAKER_01And whether they're used at CMS or not, I think CMS is thinking about, and maybe this gets to your more specific question. CMS is using AI to figure out whether or not something is appropriate for an individual patient, whether or not it's medically necessary.
SPEAKER_03When you were at CMS, a little thing called Hurricane Katrina happened, right?
SPEAKER_00It sure did.
SPEAKER_03And maybe I'm wrong to conflate these two ideas, but I I thought I thought about that and I thought about uh COVID. These are two situations that hit us out of the blue. And now you don't have the luxury of time to start making major league decisions that will have major league consequences on a lot of lives, right? Katrina in a more isolated area, COVID, of course, worldwide. What did you take from your Katrina experience and what did were your observations as this country dealt with COVID that maybe provide some lessons?
SPEAKER_01I do see them as linked, interestingly, and specifically from a CMS perspective. So, first of all, it's totally random. Why would CMS be involved in Hurricane Katrina recovery efforts? Well, healthcare providers in New Orleans did not know who to call for help, whether they needed ICE, whether they needed medicines, whether they were trapped. I mean, quite literally, a whole myriad of issues. And I'll tell you who they knew in the federal government. They knew CMS.
SPEAKER_01Medicare was paying them. They either were dealing with a Medicare administrative contractor, they might have a way to call someone in the regional office that they'd worked with before. Who knows? And we were absolutely inundated with requests that had nothing to do with Medicare and Medicaid, but more to do with how could we help get someone from FEMA to help them or whatever it was that they needed. Nature aboards a vacuum, and so do I. So we quickly were figuring out how we could step in and try and help these poor people who had been so devastated by all the flooding and the and the levees breaking because of Katrina.
SPEAKER_01And through our Office of General Counsel and a number of people who worked at CMS, we were very creative and trying to figure out how could we take payment streams that would have otherwise been intended to cover, you know, Medicare beneficiary reimbursement in a hospital or wherever else, and turn that into something that could help them. And I think to link it to COVID, a lot of the things that we figured out how to work, they pulled back out.
SPEAKER_01And of course, some of my colleagues were back at CMS when COVID originally hit and said, wait, I remember we used all these different things. People at CMS were hearing, how do we get PPE? How do we get the masks? How do we get the gowns? How do we get ventilators? How do we pay for all these things in a way that can alleviate the issues that we've got here when we don't have Medicare beneficiaries knocking down our door? How do we keep hospitals open when people aren't going to them? What do we do with skilled nursing facilities?
SPEAKER_01And it does come fast and furious.
SPEAKER_03So let's just assume we're about to go through the midterms. Heaven knows what's going to happen. But certainly there will be some kind of change, changes afoot. And then after the midterms, Leslie, since healthcare is always like a top three issue, right? The American public wants to see continued progress on healthcare, right? If you were in a position to wave a magic wine and focus on one reform coming out of the midterms, one idea, what kind of thing would you entertain given your background?
SPEAKER_01Well, I think figuring out a way to cover AI in healthcare is going to be super important. It doesn't fit neatly into any of the benefit categories. It's not necessarily a physician service. It isn't necessarily a hospital service, but I can imagine it becoming a super important part of our day to day healthcare system. I know from experience where you'll see a terrific advance. Some companies, uh, say a medical device company has spent a lot of time and energy on a medical advancement, but didn't appreciate whether or how CMS would cover it and how much it would be reimbursed.
SPEAKER_00Right.
SPEAKER_01So something is fabulous and but it cost$1,000, but reimbursement is$100, it's never going to be disseminated.
SPEAKER_00Right.
SPEAKER_01So how do you do that in a way that makes sense? Because I think in order for it to be widely disseminated, that's likely going to need to happen.
SPEAKER_03Do you miss government service?
SPEAKER_01Uh, not really. I loved my six years at CMS and my four years at the White House and the trade office. It was a fabulous decade. And the problems and the opportunities to talk to people about it, to testify before Congress, to talk to people like you, meet with CEOs, members of Congress, senators, governors, all that to try and figure out how you're going to solve these problems was fantastic.
SPEAKER_01I got very old very fast. I really like being on the other side of it to try and explain to people how they work, what's important, why it's important, um, how to teach people what the impacts are, things that CMS might care about, things they might not care about. I think it's all important. And I think it's important for people who leave government to teach the private sector. And similarly, as I was saying at the beginning, it's important for people in the private sector to not assume that people in government understand their business and to explain it to them in a way that they can go through the cost, quality, and access triple aim and what they do is important and why it has a positive impact on Medicare beneficiaries.
SPEAKER_03When you're advising private companies and you're who have shareholders and they they have bottom lines that they're they're and employees, where is the line between profitability and doing their part to advance America's health care?
SPEAKER_01I think that there is a reasonable assumption for you know what makes sense from a margin perspective. So, first of all, it's important to do things efficiently. So can you be efficient in what you're providing? It's again cost quality access triple-aim. Can you provide care efficiently? Can you provide quality care? I think the medpack approach, so medPAC is the organization that briefs Congress on typically on whether or not rates should go up or down in any of these payment sectors that I was mentioning before.
SPEAKER_01One of the things they do is look at provider margin, beneficiary access, quality of care. They have a whole host of things that they review when making the recommendation to Congress that payment should go up, go down, say the same. And it's not as if you can't have margin in healthcare. Because if you don't have margin, you don't have services. You go bankrupt. You go out of business. So I think margin is super important. If you do a particularly good job at something and you're saving people's lives, so if you're a prescription drug company, for example, people focus on a particular drug.
SPEAKER_01Oh, I can tell you it takes a lot of money to develop one drug, and there are a whole load of failures that come before it. I think what happens is people get upset when the margins get to be well into double digits or more than that. And MedPack is the first to say, you could reduce your Medicare reimbursement today. But you can look at it in a vacuum and say, okay, this prescription drug, for example, is very expensive. Okay, yeah, probably was expensive to develop.
SPEAKER_01Are you keeping someone out of a hospital? Um, how much would surgery have cost if someone's in the hospital? What's the quality of life of the individual? So I think there is um a balance there and that's recognized by at least some uh regulators. But when you cut something too much and you lose access and you lose quality, that's also not good. So the question is, you know, we're finding that sweet spot basically.
SPEAKER_03But do you ever sit back and say, my gosh, and think about all the things you've done, Leslie, and all the people you've never met who were helped by you, uh, and by all those around you that, you know, a lot of times it's a thankless task that you do, especially in government. Who goes to CMS with flowers and everything else? That's generally it's usually complaints and you know demands, right? Does it ever, as a human being, kind of like fill you as with a an added sense of having contributed something beyond yourself?
SPEAKER_01If I reflect, maybe someday it will. I think most of the time I'm very forward-looking and trying to figure out what's the next problem I can have, how can I solve it?
SPEAKER_00Right.
SPEAKER_01Uh, how can I help individual private companies or uh or the government uh figure out the triple aim? And I maybe can do that from the outside as opposed to the inside. Maybe I'll look back and think, wow, that's it is kind of cool that I can't believe it's been 20 years, that the drug benefit was as successful as it was. And it wasn't just me, certainly. You know, loads and loads of people, both inside and outside government, were responsible for ensuring that tens of millions of Medicare beneficiaries now have prescription drug coverage.
SPEAKER_01It's you know, that's pretty cool.
SPEAKER_03I really appreciate your time on the show. I think we can't know enough about healthcare. The more knowledge and information I think that shares, the better. It tends to be very confusing. I can tell you, my wife, Liz, who's, you know, got her PhD from UNC and Public Health, has been in healthcare her entire career. I'm like taking notes sometimes, at least mental notes, when she's trying to decipher something for me in the healthcare arena, which is I think one of the challenges moving forward that maybe we should revisit how we communicate healthcare, much less deliver it.
SPEAKER_03But what you've delivered and what you've been a part of, going back to your government service and now, you know, in the private sector with real innovators, we need more or less even more walks in this life.
SPEAKER_01Thank you. Thank you very much. Great to be with. Good to be with you, too. Thanks for having me.
Send us Fan Mail Former Democratic Senator Bill Bradley of New Jersey and former Republican Senator Jack Danforth of Missouri join Adam Goodman on 13th and Park for a wide-ranging conversation about the state of...
Send us Fan Mail California State Senator Brian Jones joins Anthony on 13th and Park for a candid end-of-career conversation reflecting on 16 years in Sacramento, the unique pressures of leading a super minority caucus,...
Send us Fan Mail Adam Hasner, President of Florida Atlantic University and Florida's former House Majority Leader, joins Adam Goodman on 13th and Park for a conversation about what a college education should actually...
Send us Fan Mail Larry Sabato, founder of UVA's Center for Politics and the mind behind the legendary Sabato's Crystal Ball, joins Adam Goodman for his third appearance on 13th and Park. With Election Day closing in,...
Send us Fan Mail John Zecca, NASDAQ's Executive Vice President and Global Legal Chief, joins Adam Goodman on 13th and Park for a wide-ranging conversation on what makes American capital markets the envy of the world,...